Global At-Home Drug of Abuse (DOA) Testing Market Insights and Forecast to 2028

Q: How big is the athome drug of abuse doa testing market?

The athome DOA testing market has been categorized into rapid DOA test kits and breath analyzers.Market Analysis and Insights Global AtHome Drug of Abuse DOA Testing MarketThe global AtHome Drug of Abuse DOA Testing market size is projected to reach US 862.3 million by 2028 from US 413.2 million in 2021 at a CAGR of 10.6 during 20222028.The market is mainly driven by the increased production and trade of illicit drugs worldwide growing use of illicit drugs amongst teenagers and initiatives by government organizations to reduce the level of drug abuse.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global AtHome Drug of Abuse DOA Testing market to help players in achieving a strong market position.

Q: Who are the key players in the athome drug of abuse doa testing market?

Some of the key players are UCP Biosciences, Orient New Life Medical, Express Diagnostics Int'l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm Biosciences, Phamatech, Home Health (U.K.) Ltd., Quest Products, China, Others.

Code: QYRE-Auto-32I2193

Report

January 2022

96 Pages

QYResearch

Region: Global,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

UCP Biosciences

Orient New Life Medical

Express Diagnostics Int'l

Assure Tech (Hangzhou)

Psychemedics Corporation

Confirm Biosciences

Phamatech

Home Health (U.K.) Ltd.

Quest Products

At Home Drug of Abuse Testing Market Statistics 2028

The global At-Home Drug of Abuse (DOA) Testing market size is projected to reach US$ 862.3 million by 2028, from US$ 413.2 million in 2021, at a CAGR of 10.6% during 2022-2028. The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.

The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global At-Home Drug of Abuse (DOA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global At-Home Drug of Abuse (DOA) Testing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global At-Home Drug of Abuse (DOA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global At-Home Drug of Abuse (DOA) Testing market.

At Home Drug of Abuse Testing Market Size

At-Home Drug of Abuse (DOA) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global At-Home Drug of Abuse (DOA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Test Cups
Test Dip Cards
Test Strips
Others

Segment by Application

Urine
Saliva
Hair
Others

BY COMPANY

UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

FEATURED COMPANIES

UCP Biosciences

Orient New Life Medical

Express Diagnostics Int'l

Assure Tech (Hangzhou)

Psychemedics Corporation

Confirm Biosciences

Phamatech

Home Health (U.K.) Ltd.

Quest Products

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Test Cups

1.2.3 Test Dip Cards

1.2.4 Test Strips

1.2.5 Others

1.3 Market by Application

1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Urine

1.3.3 Saliva

1.3.4 Hair

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2017-2028)

2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Region

2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2017-2022)

2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028)

2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics

2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends

2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers

2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges

2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue

3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2017-2022)

3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2017-2022)

3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue

3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio

3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2021

3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served

3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service

3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type

4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2017-2022)

4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028)

5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application

5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2017-2022)

5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)

6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type

6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)

6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)

6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)

6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application

6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)

6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)

6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)

6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country

6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)

6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)

7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type

7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)

7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)

7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)

7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application

7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)

7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)

7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)

7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country

7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)

7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)

8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type

8.2.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)

8.2.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)

8.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)

8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application

8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)

8.3.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)

8.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)

8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region

8.4.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022)

8.4.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)

9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type

9.2.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)

9.2.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)

9.2.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)

9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application

9.3.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)

9.3.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)

9.3.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)

9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country

9.4.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)

9.4.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2017-2028)

10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type

10.2.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)

10.2.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)

10.2.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)

10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application

10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)

10.3.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)

10.3.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)

10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country

10.4.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)

10.4.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 UCP Biosciences

11.1.1 UCP Biosciences Company Details

11.1.2 UCP Biosciences Business Overview

11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction

11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.1.5 UCP Biosciences Recent Developments

11.2 Orient New Life Medical

11.2.1 Orient New Life Medical Company Details

11.2.2 Orient New Life Medical Business Overview

11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction

11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.2.5 Orient New Life Medical Recent Developments

11.3 Express Diagnostics Int’l

11.3.1 Express Diagnostics Int’l Company Details

11.3.2 Express Diagnostics Int’l Business Overview

11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction

11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.3.5 Express Diagnostics Int’l Recent Developments

11.4 Assure Tech (Hangzhou)

11.4.1 Assure Tech (Hangzhou) Company Details

11.4.2 Assure Tech (Hangzhou) Business Overview

11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction

11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.4.5 Assure Tech (Hangzhou) Recent Developments

11.5 Psychemedics Corporation

11.5.1 Psychemedics Corporation Company Details

11.5.2 Psychemedics Corporation Business Overview

11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction

11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.5.5 Psychemedics Corporation Recent Developments

11.6 Confirm BioSciences

11.6.1 Confirm BioSciences Company Details

11.6.2 Confirm BioSciences Business Overview

11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction

11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.6.5 Confirm BioSciences Recent Developments

11.7 Phamatech

11.7.1 Phamatech Company Details

11.7.2 Phamatech Business Overview

11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction

11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.7.5 Phamatech Recent Developments

11.8 Home Health (U.K.) Ltd.

11.8.1 Home Health (U.K.) Ltd. Company Details

11.8.2 Home Health (U.K.) Ltd. Business Overview

11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction

11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.8.5 Home Health (U.K.) Ltd. Recent Developments

11.9 Quest Products

11.9.1 Quest Products Company Details

11.9.2 Quest Products Business Overview

11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction

11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

11.9.5 Quest Products Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

UCP Biosciences

Orient New Life Medical

Express Diagnostics Int'l

Assure Tech (Hangzhou)

Psychemedics Corporation

Confirm Biosciences

Phamatech

Home Health (U.K.) Ltd.

Quest Products

List of Tables

Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Test Cups

Table 3. Key Players of Test Dip Cards

Table 4. Key Players of Test Strips

Table 5. Key Players of Others

Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)

Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2017-2022)

Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2023-2028)

Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends

Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers

Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges

Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints

Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2017-2022) & (US$ Million)

Table 17. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players (2017-2022)

Table 18. Global Top At-Home Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2021)

Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2021

Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2017-2022)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service

Table 23. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)

Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2017-2022)

Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2023-2028)

Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)

Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Application (2017-2022)

Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Application (2023-2028)

Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)

Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)

Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)

Table 36. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)

Table 37. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)

Table 38. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)

Table 39. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)

Table 40. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)

Table 41. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)

Table 42. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)

Table 43. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)

Table 44. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)

Table 45. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)

Table 46. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)

Table 47. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)

Table 48. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)

Table 49. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)

Table 50. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2023-2028) & (US$ Million)

Table 51. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)

Table 52. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)

Table 53. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)

Table 54. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)

Table 55. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)

Table 56. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)

Table 57. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)

Table 63. UCP Biosciences Company Details

Table 64. UCP Biosciences Business Overview

Table 65. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product

Table 66. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 67. UCP Biosciences Recent Developments

Table 68. Orient New Life Medical Company Details

Table 69. Orient New Life Medical Business Overview

Table 70. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product

Table 71. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 72. Orient New Life Medical Recent Developments

Table 73. Express Diagnostics Int’l Company Details

Table 74. Express Diagnostics Int’l Business Overview

Table 75. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product

Table 76. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 77. Express Diagnostics Int’l Recent Developments

Table 78. Assure Tech (Hangzhou) Company Details

Table 79. Assure Tech (Hangzhou) Business Overview

Table 80. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product

Table 81. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 82. Assure Tech (Hangzhou) Recent Developments

Table 83. Psychemedics Corporation Company Details

Table 84. Psychemedics Corporation Business Overview

Table 85. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product

Table 86. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 87. Psychemedics Corporation Recent Developments

Table 88. Confirm BioSciences Company Details

Table 89. Confirm BioSciences Business Overview

Table 90. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product

Table 91. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 92. Confirm BioSciences Recent Developments

Table 93. Phamatech Company Details

Table 94. Phamatech Business Overview

Table 95. Phamatech At-Home Drug of Abuse (DOA) Testing Product

Table 96. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 97. Phamatech Recent Developments

Table 98. Home Health (U.K.) Ltd. Company Details

Table 99. Home Health (U.K.) Ltd. Business Overview

Table 100. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product

Table 101. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 102. Home Health (U.K.) Ltd. Recent Developments

Table 103. Quest Products Company Details

Table 104. Quest Products Business Overview

Table 105. Quest Products At-Home Drug of Abuse (DOA) Testing Product

Table 106. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)

Table 107. Quest Products Recent Developments

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2021 VS 2028

Figure 2. Test Cups Features

Figure 3. Test Dip Cards Features

Figure 4. Test Strips Features

Figure 5. Others Features

Figure 6. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2021 VS 2028

Figure 7. Urine Case Studies

Figure 8. Saliva Case Studies

Figure 9. Hair Case Studies

Figure 10. Others Case Studies

Figure 11. At-Home Drug of Abuse (DOA) Testing Report Years Considered

Figure 12. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 13. Global At-Home Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region: 2021 VS 2028

Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2021

Figure 16. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2021)

Figure 17. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2021

Figure 18. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)

Figure 19. North America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)

Figure 20. North America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)

Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)

Figure 22. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)

Figure 25. Europe At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)

Figure 26. Europe At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)

Figure 27. Europe At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)

Figure 28. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Nordic Countries At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)

Figure 35. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)

Figure 36. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)

Figure 37. Asia Pacific At-Home Drug of Abuse (DOA) Testing Market Size Share by Region (2017-2028)

Figure 38. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)

Figure 45. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)

Figure 46. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)

Figure 47. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)

Figure 48. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)

Figure 51. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)

Figure 52. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)

Figure 53. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)

Figure 54. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. UAE At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. South Africa At-Home Drug of Abuse (DOA) Testing Revenue (2017-2028) & (US$ Million)

Figure 58. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 59. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 60. Express Diagnostics Int’l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 61. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 62. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 63. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 64. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 65. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 66. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2017-2022)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global At-Home Drug of Abuse (DOA) Testing Market Insights and Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Analytical Instruments for Drug Screening Market

Drug Screening Equipment Market

Drug Screening Test Kit Market

Drug Screening Laboratory Service Market

Drug Designing Tools Market

Alcohol Breathalyzer and Drug Testing Market

At Home Drug of Abuse DOA Testing Market

Drug of Abuse Testing Services Market

Workplace Drug Testing Service Market

Drug Testing Market

Bacterial Identification and Drug Sensitivity Testing Market

Orphan Drugs Market

Global At-Home Drug of Abuse (DOA) Testing Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-32I2193

Global At-Home Drug of Abuse (DOA) Testing Market Insights and Forecast to 2028

Code: QYRE-Auto-32I2193

Report

January 2022

96 Pages

QYResearch

Region: Global,

FEATURED COMPANIES

At Home Drug of Abuse Testing Market Statistics 2028

At Home Drug of Abuse Testing Market Size

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-7R6112

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-24O5685

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-38U5811

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-0O6236

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions